<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: This study evaluated the effects of black raspberries (BRBs) on biomarkers of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development in the human colon and rectum including methylation of relevant <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes, cell proliferation, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, and expression of Wnt pathway genes </plain></SENT>
<SENT sid="1" pm="."><plain>EXPERIMENTAL DESIGN: Biopsies of adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissues and colorectal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> were taken from 20 patients before and after oral consumption of BRB powder (60 g/d) for 1-9 weeks </plain></SENT>
<SENT sid="2" pm="."><plain>Methylation status of promoter regions of five <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes was quantified </plain></SENT>
<SENT sid="3" pm="."><plain>Protein expression of DNA methyltransferase 1 (DNMT1) and genes associated with cell proliferation, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, and Wnt signaling were measured </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The methylation of three Wnt inhibitors, SFRP2, SFRP5, and WIF1, upstream genes in Wnt pathway, and PAX6a, a developmental regulator, was modulated in a protective direction by BRBs in <z:mpath ids='MPATH_458'>normal</z:mpath> tissues and in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> only in patients who received BRB treatment for an average of 4 weeks, but not in <z:hpo ids='HP_0000001'>all</z:hpo> 20 patients with 1-9 weeks of BRB treatment </plain></SENT>
<SENT sid="5" pm="."><plain>This was associated with decreased expression of DNMT1 </plain></SENT>
<SENT sid="6" pm="."><plain>BRBs modulated expression of genes associated with Wnt pathway, proliferation, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> in a protective direction </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These data provide evidence of the ability of BRBs to demethylate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes and to modulate other biomarkers of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development in the human colon and rectum </plain></SENT>
<SENT sid="8" pm="."><plain>While demethylation of genes did not occur in colorectal tissues from <z:hpo ids='HP_0000001'>all</z:hpo> treated patients, the positive results with the secondary endpoints suggest that additional studies of BRBs for the prevention of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in humans now appear warranted </plain></SENT>
</text></document>